A counterfeit Ethereum layer-2 network branded as GIWA deceived 1,335 users into depositing about 767.65 ETH into a fake bridge, resulting in a loss of approximately 766.25 ETH. The fake network launched on September 26 and mimicked legitimate infrastructure but was not an official mainnet, which GIWA confirmed is still under development. DYORSWAP, a related platform, has reimbursed over 200 ETH to affected users and is investigating the operators and fund destinations. The incident highlights risks in interacting with unreleased blockchain projects and fake bridges.
The fake GIWA Ethereum Layer 2 bridge scam is the subject, with Pluang market data providing context as of Sep 28, 2026 13:21 WIB. For readers following major cryptocurrencies, here is Pluang's market snapshot: out of 50 priced assets, 9 rose and 40 fell today. Notable movers include COMP at Rp421.862 with a 1-day change of -5.73% and a typical hold time on Pluang of 97 days, SUSHI at Rp4.552 down 5.17%, and VET at Rp158 down 5.14%.
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
